文献速递细菌感染、耐药与抗菌药物

质量奖金财务激励如何影响初级保健中的抗生素处方:CCG与全科实践专业人员的观点

How did a Quality Premium financial incentive influence antibiotic prescribing in primary care? Views of Clinical Commissioning Group and general practice professionals.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究通过半结构化电话访谈22名CCG和19名全科实践专业人员,探讨质量奖金(QP)的实施情况及对英格兰初级保健抗生素处方的影响。受访者认为QP通过提升抗菌药物管理优先级和设定处方目标来促进改变,而非通过额外资金,且沟通不足、资源与背景因素影响实施与可持续性。

要点

  • QP主要通过提升AMS优先级和设定处方目标来影响处方行为,而非资金再投入。
  • 沟通被认为不结构化且不频繁,CCG人员不确定是否获得QP资金。
  • 实施受当地资源和竞争性优先事项影响,多层面定制策略最有助于全科实践参与。

核心结论

  • CCG和实践专业人员对QP及相关处方目标和反馈持积极看法。
  • QP主要通过提升AMS优先级和定义改变目标来帮助影响改变,而非提供额外资金。
  • 为最大化影响,应在实施前考虑财务激励的行为机制。

研究设计与样本

  • 对22名CCG和19名全科实践专业人员进行了半结构化电话访谈。
  • 访谈采用主题分析法进行分析。

主要发现

  • 沟通方面,感知为不结构化且不频繁,CCG专业人员不确定是否收到QP资金。
  • 实施受当地资源和竞争性优先事项影响,多层面定制策略被认为最有助于吸引全科实践。
  • 许多AMS策略独立于QP实施,动机为质量改进。
  • 机制上,QP提升了AMS在国家与地方的优先级,提供了处方目标和基准,但资金未被视为再投资于AMS。
  • 影响与可持续性方面,QP被认为成功,但少数CCG和实践因背景因素认为目标具有挑战性;CCG人员担忧QP可能终止及处方率趋于平稳。

临床怎么用

  • 在实施财务激励前应考虑其行为机制以最大化影响。
  • 采取多层面定制策略以吸引全科实践参与AMS。
  • 加强沟通并明确资金流向,避免CCG人员不确定是否收到QP资金。
  • 关注背景因素(如贫困、人手不足)对实现处方目标的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Quality Premium (QP) was introduced for Clinical Commissioning Groups (CCGs) in England to optimize antibiotic prescribing, but it remains unclear how it was implemented. OBJECTIVES: To understand responses to the QP and how it was perceived to influence antibiotic prescribing. METHODS: Semi-structured telephone interviews were conducted with 22 CCG and 19 general practice professionals. Interviews were analysed thematically. RESULTS: The findings were organized into four categories. (i) Communication: this was perceived as unstructured and infrequent, and CCG professionals were unsure whether they received QP funding. (ii) Implementation: this was influenced by available local resources and competing priorities, with multifaceted and tailored strategies seen as most helpful for engaging general practices. Many antimicrobial stewardship (AMS) strategies were implemented independently from the QP, motivated by quality improvement. (iii) Mechanisms: the QP raised the priority of AMS nationally and locally, and provided prescribing targets to aim for and benchmark against, but money was not seen as reinvested into AMS. (iv) Impact and sustainability: the QP was perceived as successful, but targets were considered challenging for a minority of CCGs and practices due to contextual factors (e.g. deprivation, understaffing). CCG professionals were concerned with potential discontinuation of the QP and prescribing rates levelling off. CONCLUSIONS: CCG and practice professionals expressed positive views of the QP and associated prescribing targets and feedback. The QP helped influence change mainly by raising the priority of AMS and defining change targets rather than providing additional funding. To maximize impact, behavioural mechanisms of financial incentives should be considered pre-implementation.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Borek AJ, Anthierens S, Allison R, et al. How did a Quality Premium financial incentive influence antibiotic prescribing in primary care? Views of Clinical Commissioning Group and general practice professionals. J Antimicrob Chemother. 2020. PMID: 32573692. doi:10.1093/jac/dkaa224

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。